Farmas USA

Al tipo este le veo hasta en la sopa

http://seekingalpha.com/instablog/498952-bret-jensen/4947247-tracon-pharmaceuticals-5-biotech-stock-plenty-catalysts-2017

TCON

oh no! bret Jensen! ...ya me has quitado el interés! jajajaja. es un horror como analista
PD: Hoy ya toca rebote en las bios

Las velas de ayer de XBI/IBB eran de rebote, si, veremos por cuanto.

Hoy compro HZNP en apertura lo mas probable y largo las REGN en cuanto verdeen y le saque unos pavos.

FDA introduces regenerative advanced therapy designation

Eligible regenerative therapies are defined as cell therapies, therapeutic tissue engineering products, human cell and tissue products. Some combination products are also eligible. Products eligible for the designation must treat a "serious or life-threatening" disease or condition, and preliminary clinical evidence must show that it may address an unmet need.

Therapies receiving the designation are eligible for Priority Review and accelerated approval.

Sponsors are to request the designation when submitting an IND, or in an amendment. Within 60 days, FDA's new Office of Tissues and Advanced Therapies is to inform the sponsor about its decision. The office must explain any decision not to grant the designation.

http://www.biocentury.com/dailynews/politics/2017-01-24/fda-introduces-regenerative-advanced-therapy-designation?utm_source=Twitter&utm_campaign=auto_social&utm_medium=web

MYOV
Myovant Sciences launches late-stage relugolix studies in uterine fibroids
http://www.seekingalpha.com/news/3237312

Hoy estos valores , tienen parte de mi atención ....🤔

ESPR
Enrolment completado
http://investor.esperion.com/releasedetail.cfm?ReleaseID=1009056

Buenas tardes.
Me vuelvo a poner corto en el EUN2 SToxx.
Virgencita, virgencita
A 33,79